MXPA04002640A - Esteres de analogos de 3-desoxi-vitamina d3. - Google Patents

Esteres de analogos de 3-desoxi-vitamina d3.

Info

Publication number
MXPA04002640A
MXPA04002640A MXPA04002640A MXPA04002640A MXPA04002640A MX PA04002640 A MXPA04002640 A MX PA04002640A MX PA04002640 A MXPA04002640 A MX PA04002640A MX PA04002640 A MXPA04002640 A MX PA04002640A MX PA04002640 A MXPA04002640 A MX PA04002640A
Authority
MX
Mexico
Prior art keywords
desoxy
vitamin
analog esters
esters
analog
Prior art date
Application number
MXPA04002640A
Other languages
English (en)
Inventor
Radoje Uskokovic Milan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA04002640A publication Critical patent/MXPA04002640A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a compuestos de acuerdo con la formula I (ver formula) o una sal del mismo, donde la linea de puntos, R1, R2, R3, R4 y L son tal como se definen en las reivindicaciones. La invencion ademas se refiere al uso de los compuestos de formula I o sales de los mismos como medicamentos.
MXPA04002640A 2001-09-21 2002-09-12 Esteres de analogos de 3-desoxi-vitamina d3. MXPA04002640A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32387001P 2001-09-21 2001-09-21
US32395701P 2001-09-21 2001-09-21
PCT/EP2002/010233 WO2003027065A1 (en) 2001-09-21 2002-09-12 3-desoxy-vitamin d3 analog esters

Publications (1)

Publication Number Publication Date
MXPA04002640A true MXPA04002640A (es) 2004-06-07

Family

ID=26984180

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002640A MXPA04002640A (es) 2001-09-21 2002-09-12 Esteres de analogos de 3-desoxi-vitamina d3.

Country Status (14)

Country Link
EP (1) EP1430026A1 (es)
JP (1) JP2005503434A (es)
KR (1) KR100628586B1 (es)
CN (1) CN1285573C (es)
AU (1) AU2002338672B2 (es)
BR (1) BR0212719A (es)
CA (1) CA2459789A1 (es)
MX (1) MXPA04002640A (es)
PA (1) PA8554901A1 (es)
PE (1) PE20030429A1 (es)
PL (1) PL370352A1 (es)
RU (1) RU2296121C2 (es)
UY (1) UY27448A1 (es)
WO (1) WO2003027065A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1556345B1 (en) * 2002-10-23 2010-12-15 Leo Pharma A/S Vitamin d analogues, compositions comprising said analogues and their use
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
WO2010020966A2 (en) 2008-08-22 2010-02-25 Nxp B.V. Location-based services
CN110339205B (zh) * 2019-08-19 2021-08-24 山东德信生物科技有限公司 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
AU1022999A (en) * 1997-09-08 1999-03-29 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs

Also Published As

Publication number Publication date
KR100628586B1 (ko) 2006-09-26
RU2004112217A (ru) 2005-07-10
JP2005503434A (ja) 2005-02-03
PA8554901A1 (es) 2003-12-10
EP1430026A1 (en) 2004-06-23
KR20040035853A (ko) 2004-04-29
UY27448A1 (es) 2003-03-31
WO2003027065A1 (en) 2003-04-03
RU2296121C2 (ru) 2007-03-27
PE20030429A1 (es) 2003-05-15
AU2002338672B2 (en) 2006-03-09
CN1556795A (zh) 2004-12-22
BR0212719A (pt) 2004-08-03
CN1285573C (zh) 2006-11-22
PL370352A1 (en) 2005-05-16
CA2459789A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
IL176062A0 (en) Dpp-iv inhibitors
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
SI1585739T1 (sl) Substituirani arilciklopropilacetamidi kot aktivatorji glukokinaze
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
AP2002002637A0 (en) Novel piperazine
BG106585A (en) Kinase inhibitors as therapeutic agents
MY135841A (en) Novel benzodioxoles
TNSN06405A1 (en) Quinazolinone derivatives useful as vanilloid antagonistes
PL361355A1 (en) Phenylglycine derivatives
GEP20084284B (en) Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
YU30603A (sh) Derivati premošćenog piperazina
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
GB0212410D0 (en) Organic compounds
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
MXPA04002640A (es) Esteres de analogos de 3-desoxi-vitamina d3.
MXPA06000372A (es) Compuestos de silicio y su uso.
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
FG Grant or registration